New Jersey's S4509 banned intoxicating hemp products including THCA in 2026, leaving only narrow legal categories and forcing retailers to act immediately.
Connecticut introduced a 173-page bill in February 2026 rewriting marijuana and hemp licensing, THC limits, and infused beverage rules in the state code.
Texas hemp operators face TABC rule finalization, a March 31 smokable product ban, and HB 46 medical cannabis expansion reshaping the 2026 market.
New Jersey's S4509, signed January 2026, ends the intoxicating-hemp grey market with a licensing regime, age gates, and a fundamental compliance reset.
Oregon OLCC bulletin CE2025-06 stopped requiring Labor Peace Agreements as a licensing gate for affected Measure 119 license types in May 2025.
Wisconsin gave hemp vape devices a directory carveout delaying the sell prohibition to July 1, 2026 and dollar-per-day forfeitures to September 1, 2026.
Quebec SQDC launched cannabis vape sales on 26 November 2025 under a 30 percent THC concentration cap and a framework allowing only cannabis terpenes.
British Columbia LDB cannabis wholesale faced a BCGEU overtime ban from 12 September 2025 and a temporary closure on 22 September 2025, disrupting dispatch.
Pennsylvania's cannabis legalization momentum stalled in September 2025 after the Governor urged a pause on new bills, leaving hemp THC drinks in limbo.
Colombia's Decree 1138 of October 27, 2025 recognizes dried medical cannabis flower as a finished product, opening pharmacy dispensing and exports.
Florida's 2025 Operation Safe Summer pulled more than 155,000 hemp packages under Rule 5K-4.034 for youth appeal, packaging, and labeling failures.
Health Canada removed the 60-day Notice of New Cannabis Product for dried and fresh cannabis in 2025, speeding flower launches without easing testing.
A new Pennsylvania hemp trade group launched late 2025 is pushing age-21 access, potency caps, and a clear line between CBD wellness and delta-8 products.
FDA's September 9, 2025 deceptive drug advertising push and roughly 100 cease-and-desist letters raise the claim-substantiation bar for CBD and THC drinks.
California DCC mid-2025 rulemaking overhauls cannabis pesticide action levels with DPR health-based input, raising COA, method, and recall transition risk.
USP republished draft General Chapter 1568 and the proposed CBD monograph in Pharmacopeial Forum 51(3) for September to October 2025 cannabis research review.
Luxembourg ended prescription access to primarily THC-rich medical flower from January 1, 2025, favoring oils and standardized preparations for dosing.
Argentina's Resolution 1780/2025 tightens REPROCANN eligibility, documentation, and traceability for therapeutic cultivation, transport, and derivatives.
California's CDPH emergency ingestible hemp rules sunset September 23, 2025, putting inventory, ecommerce, and labeling on the DPH-24-005 rulemaking clock.
Elgin's 2025 ordinance bans intoxicating delta-8 and delta-9 hemp edibles outside the state-licensed system, signaling a rising Illinois municipal ban trend.
Chicago Ordinance O2025-0018771 would set age-21 hemp and kratom sales, retailer permits, and a possible city tax on THC drinks under new Chapter 4-65.
DOJ's September 2025 Federal Register notice withdrew DEA rulemakings on analytical labs and hemp (RIN 1117-AB77) and cannabis research (RIN 1117-AB83).
The Philippines House approved House Bill 10439 in 2025, creating a Medical Cannabis Office and a market architecture now awaiting Senate consideration.
Morocco logged its first legal cannabis exports in 2025 with 67 ANRAC-approved products under Law 13-21, opening medical and industrial supply channels.
Colombia's 2025 draft decree would authorize pharmacy sales of medical cannabis flower with new dispensing rules and marketing limits for licensed operators.
Ukraine's State Service authorized first medical cannabis import permits on June 2, 2025, expanding dosages and pharmacy readiness across the program.
Pennsylvania's 2025 legislative push to regulate hemp-derived THC beverages debates age-21 sales, potency caps, and which retail channels can lawfully sell.
CBP, FDA, and USPS intensified 2025 de minimis enforcement against vape device imports, raising new compliance and seizure risk for hemp hardware buyers.
Texas Executive Order GA-56 from September 10, 2025 directs DSHS, TABC, and DPS to tighten hemp THC retail rules amid a Lt. Gov. Patrick powers fight.
More than 30 state and territorial Attorneys General in 2025 urged Congress to close the 2018 Farm Bill loophole on intoxicating delta-8 THC and THCA products.
California ABC bars licensed bars and restaurants from selling industrial hemp food or drinks on-premise, pairing with CDPH emergency intoxicating hemp rules.
Texas Executive Order GA-56 issued September 10, 2025 directs DSHS, TABC, and DPS to attack hemp THC sales to minors with ID rules and revocations.
CBP's January 2025 proposed rule rewrites the Section 321 de minimis exemption, ending duty-free entry for low-value CBD and hemp-derived cannabinoid shipments.
US Virgin Islands' Office of Cannabis Regulation opened adult-use cultivation applications March 31, 2025 with phased windows, local ownership rules, and Metrc.
Health Canada's July 2025 CTLS data integrity crackdown raises personnel and ownership reporting stakes for licensees while easing minor CAPA paperwork.
Texas Executive Order GA-56 in September 2025 bans hemp-derived THC sales to minors, mandates ID checks, and adds DSHS and TABC enforcement on consumable hemp.
California AB 8 in September 2025 would move intoxicating hemp products like delta-8 and THCa into the regulated cannabis system and ban synthetic cannabinoids.
FinCEN's March 26, 2025 interim final rule scrapped Corporate Transparency Act BOI filing for U.S. entities, shifting cannabis and hemp KYC duties onto banks.
West Virginia's ABCA hemp and kratom retail rule, effective May 15, 2025, requires retailer permits, age-21 sales, and on-site CBD compliance.
Portugal's INFARMED tightened 2025 import and export rules for medical cannabis, adding new documents, timelines, and compliance steps for licensees.
Denmark made its medical cannabis program permanent in 2025 after years of pilot operation, locking in prescribing rules, licensing, and driving guidance.
California's 2025 hemp enforcement pairs Newsom's 99.7% compliance claim with padlock actions and online stings, mapping new risks for retailers.
USPS revoked B2B vape shipping privileges for non-compliant distributors in August 2025. What hemp THC operators must do to avoid seizures and account loss.
North Dakota's 2025 medical cannabis edibles rollout introduces packaging, labeling, and dosing requirements that dispensaries and processors must meet.
Israel's 2025 medical cannabis rules expand specialist prescribing authority with a December go-live, adding steps for importers and pharmacies.
Texas DSHS will issue Q4 2025 hemp cannabinoid rules on testing, labeling, fees, and multi-agency oversight that retailers must prepare for now.
Ontario's AGCO 2025 online compliance push requires the retail seal, RSA display, and website submission for licensed stores selling cannabis online.
After the Senate dropped the detectable-THC ban from the 2025 Ag-FDA bill, intoxicating hemp's federal status stays unresolved heading into next year.
The Missouri Supreme Court ended local tax stacking on adult-use cannabis, forcing pricing, refunds, and POS configuration changes for dispensaries.
New York's 2025 crackdown expanded padlock authority and revived a THC potency cap debate, forcing licensee action on enforcement and signage.
A 2025 Wyoming court ruling kept the state's delta-8 ban while HB0267 proposes a 10 mg THC beverage carveout, leaving operators in split posture.
Delaware paused HB 98 in 2025, leaving hemp-derived THC beverages in a regulatory gray zone outside the proposed alcohol and dispensary distribution channels.
Kansas SB 292 targets intoxicating hemp in 2025 with age-21 sales, potency caps, and mandatory testing, reshaping retail and manufacturer duties.
Oregon's Recycling Modernization Act 2025 EPR duties pull cannabis and hemp packaging into producer responsibility, adding registration, fees, reports.
Vermont's new Hemp and Beverage Coalition is pushing 2025 legislative clarity for hemp-derived THC drinks amid unresolved gray areas in state cannabis law.
New Mexico's Environment Department emergency rule effective September 1, 2025 bans synthetic and chemically converted hemp cannabinoids like delta-8.
Thailand is recriminalizing recreational cannabis in 2025, restricting sales to prescription medical patients and adding cannabis to the narcotics list.
Montana HB 49, signed April 7, 2025, caps hemp products at 0.5 mg delta-9 THC per serving and 2 mg per package, effectively ending intoxicating hemp sales.
Milwaukee adopted age-21 sales protocols for delta-8 and intoxicating hemp products in July 2025, filling Wisconsin's lack of a statewide hemp standard.
FDA opened Docket FDA-2025-N-0001 in January 2025 seeking data on cannabis-derived veterinary products, signaling federal rules ahead for pet CBD makers.
USDA extended its DEA-registered lab testing deadline for hemp through December 31, 2025 — what growers and state plan administrators should do next.
FDA's June 2025 proposal under Docket FDA-2024-N-5468 adds hemp cannabinoids to adverse-event reporting, raising new surveillance risk for CBD and CBG brands.
Louisiana Department of Health emergency rules, effective May 2, 2025, cap hemp at 5 mg THC per serving and require a 12-fluid-ounce minimum for beverages.
Ohio's 2025 intoxicating hemp bill would push delta-8 and similar cannabinoids into dispensary-only sales with potency caps as it moves through the Statehouse.
A Massachusetts House bill advanced in June 2025 would place intoxicating hemp beverages under the Cannabis Control Commission with new age and potency limits.
New Jersey's 2025 emergency rules under S3235 and S4509 ban THCA, delta-8, and HHC outside the licensed cannabis system, with $10,000 per-violation fines.
Connecticut's hemp rules effective October 1, 2025 cap manufactured hemp products at 1 milligram THC per serving, among the strictest state thresholds.
In July 2025, the US Senate stripped hemp-restricting language from the draft Agriculture Appropriations Bill, preserving the legality of hemp-derived products.
California's emergency ban on hemp products with detectable THC reshapes the state's CBD and hemp sector with new compliance obligations and enforcement risks.
Between June 10 and 19, 2025, Montana froze cannabis license expansion, Mississippi's AG curbed hemp consumables, and North Carolina advanced hemp legislation.
April 19, 2026
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
